Strategies for chemopreventative drug development are based on the use of well-characterized agents, intermediate biomarkers correlating to cancer incidence, and suitable cohorts for efficacy studies. Since
Ronald A. Lubet, PhD
Advertisement
Articles by Ronald A. Lubet, PhD
Advertisement
Latest Updated Articles
- Strategies for Identification and Clinical Evaluation of Promising Chemopreventive Agents
Published: October 1st 1996 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Ficerafusp Alfa/Pembrolizumab Receives FDA BTD in Front-Line HNSCC
2
Tucatinib Regimen Improves PFS in HER2+ Metastatic Breast Cancer
3
ESMO 2025: Key Anticipated Updates in Breast and Lung Tumors
4
Safety Strategies for GPRC5D-Directed and T-Cell Engager Therapies
5
